Disclosures for "Contribution of the Mitochondrial Complex I Inhibitor Annonacin to the Alpha-synuclein/Tau Co-pathology in Caribbean Atypical Parkinsonism"
-
Dr. González-Lizárraga has nothing to disclose.
-
Dr. Boluda has nothing to disclose.
-
Dr. Ruiz Hidalgo has nothing to disclose.
-
The institution of Prof. Avila has received research support from SCAIT-UNT. The institution of Prof. Avila has received research support from FONCyT.
-
Dr. Socias has nothing to disclose.
-
Dr. Medina has nothing to disclose.
-
Mr. Chaumont has nothing to disclose.
-
Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
-
The institution of Prof. Chehin has received research support from FONCyT. The institution of Prof. Chehin has received research support from CONICET. The institution of Prof. Chehin has received research support from SCAIT. Prof. Chehin has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Vozari has nothing to disclose.
-
Dr. Michel has nothing to disclose.
-
Dr. Lannuzel has nothing to disclose.